Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation of TNF blockers in rheumatoid arthritis with stable low disease activity
NL-OMON35995Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2012
- Countries
- 1
01
Overview
Open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Percentage of patients with rheumatoid arthritis exacerbation during the first year. Started Mar 2012; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON35995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35995.